No Data
No Data
Shandong Xinhua Pharmaceutical Eyes Stake in Nutritional Oil Refining Firm
Announcement highlights | Longfor Group's sales exceeded 90 billion yuan this year; Mao Geping announced the lottery results, listed this morning.
In the first 11 months, longfor group achieved a total contract sales amount of 93 billion yuan, with contract sales of 8.5 billion yuan in November; cspc pharma's application for marketing approval for SYHX2011 to treat advanced breast cancer was accepted.
SHANDONG XINHUA (00719) intends to acquire no more than 75% of the equity of Noah Saint New (Taicang) Biotechnology to improve the Omega-3 Industry Chain.
Shandong Xinhua (00719) announced that to improve the group's industry chain and supply chain, it is promoting the high-quality development of the health industry...
Express News | Shandong Xinhua Pharmaceutical - Novosanaeuropeb.v. to Sell Not More Than 75% of Novosana (Taicang) Co
Express News | Shandong Xinhua Pharmaceutical - Acquisition Letter of Intent in Relation to Acquisition of a Co
Bearish landing? Hong Kong stocks in the pharmaceutical sector collectively strengthen with wuxi apptec rising over 8%.
① How much impact did the biological safety legislation have on domestic pharmaceutical stocks previously? ② How do industry insiders view the subsequent development of the biological legislation?
No Data
whqqq : Will more capital flow into the Hong Kong market after the delisting crisis?
HopelessChi whqqq : future is solid red. must be some amazing news crashing the future of HSI/HST
whqqq HopelessChi : What's the bad news?
海纳百川 whqqq : It will take longer for the market to recover; currently, it is still mainly bearish
whqqq 海纳百川 : OKAY...Thank you for your answer